<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Interleukin 2</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Interleukin_2">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/mediawiki.page.gallery.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/mediawiki.page.gallery.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Interleukin 2</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Interleukin-2</b> (<b>IL-2</b>) is an interleukin, a type of cytokine signaling molecule in the immune system. It is a 15.5–16 kDa protein<span class="mw-ref" id="cite_ref-:0_5-0"><a href="#cite_note-:0-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> that regulates the activities of white blood cells (leukocytes, often lymphocytes) that are responsible for immunity. IL-2 is part of the body's natural response to microbial infection, and in discriminating between foreign ("non-self") and "self". IL-2 mediates its effects by binding to IL-2 receptors, which are expressed by lymphocytes. The major sources of IL-2 are activated CD4<sup>+</sup> T cells and activated CD8<sup>+</sup> T cells.<span class="mw-ref" id="cite_ref-Liao_2011_6-0"><a href="#cite_note-Liao_2011-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>

<table class="infobox" style="width:26.4em"><tbody><tr><th colspan="4" style="text-align:center;font-size:125%;font-weight:bold">IL2</th></tr><tr><td colspan="4" style="text-align:center"><figure-inline><img src="../I/m/IL2_Crystal_Structure.png" tppabs="https://ptable.com/wiki/compounds/I/m/IL2_Crystal_Structure.png" data-file-width="900" data-file-height="750" data-file-type="bitmap" height="208" width="250"></figure-inline></td></tr><tr><td colspan="4" style="text-align:center;background-color:#eee"><table style="padding:0;border:none;margin:0;width:100%;text-align:left"><tbody><tr><th colspan="4" style="text-align:center;background-color:#ddd">Available structures</th></tr><tr><th rowspan="2" style="background-color:#c3fdb8;width:43px">PDB</th><td colspan="2" style="background-color:#eee">Ortholog search: <span class=""><a href="javascript:if(confirm('https://www.ebi.ac.uk/pdbe/searchResults.html?display=both&term=P04351%20or%20P60568  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/pdbe/searchResults.html?display=both&term=P04351%20or%20P60568'" tppabs="https://www.ebi.ac.uk/pdbe/searchResults.html?display=both&term=P04351%20or%20P60568" class="external text external">PDBe</a> <a href="javascript:if(confirm('http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=UpAccessionIdQuery&accessionIdList=P04351,P60568  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=UpAccessionIdQuery&accessionIdList=P04351,P60568'" tppabs="http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=UpAccessionIdQuery&accessionIdList=P04351,P60568" class="external text external">RCSB</a> </span></td></tr><tr><td><table class="collapsible collapsed" style="padding:0;border:none;margin:0;width:100%;text-align:left"><tbody><tr style="background-color:#ddd;text-align:center"><th colspan="2">List of PDB id codes</th></tr><tr><td colspan="2" style="background-color:#eee"><p><span class=""><a href="javascript:if(confirm('https://www.rcsb.org/structure/1IRL  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/1IRL'" tppabs="https://www.rcsb.org/structure/1IRL" class="external text external">1IRL</a>, <a href="javascript:if(confirm('https://www.rcsb.org/structure/1M47  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/1M47'" tppabs="https://www.rcsb.org/structure/1M47" class="external text external">1M47</a>, <a href="javascript:if(confirm('https://www.rcsb.org/structure/1M48  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/1M48'" tppabs="https://www.rcsb.org/structure/1M48" class="external text external">1M48</a>, <a href="javascript:if(confirm('https://www.rcsb.org/structure/1M49  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/1M49'" tppabs="https://www.rcsb.org/structure/1M49" class="external text external">1M49</a>, <a href="javascript:if(confirm('https://www.rcsb.org/structure/1M4A  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/1M4A'" tppabs="https://www.rcsb.org/structure/1M4A" class="external text external">1M4A</a>, <a href="javascript:if(confirm('https://www.rcsb.org/structure/1M4B  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/1M4B'" tppabs="https://www.rcsb.org/structure/1M4B" class="external text external">1M4B</a>, <a href="javascript:if(confirm('https://www.rcsb.org/structure/1M4C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/1M4C'" tppabs="https://www.rcsb.org/structure/1M4C" class="external text external">1M4C</a>, <a href="javascript:if(confirm('https://www.rcsb.org/structure/1NBP  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/1NBP'" tppabs="https://www.rcsb.org/structure/1NBP" class="external text external">1NBP</a>, <a href="javascript:if(confirm('https://www.rcsb.org/structure/1PW6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/1PW6'" tppabs="https://www.rcsb.org/structure/1PW6" class="external text external">1PW6</a>, <a href="javascript:if(confirm('https://www.rcsb.org/structure/1PY2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/1PY2'" tppabs="https://www.rcsb.org/structure/1PY2" class="external text external">1PY2</a>, <a href="javascript:if(confirm('https://www.rcsb.org/structure/1QVN  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/1QVN'" tppabs="https://www.rcsb.org/structure/1QVN" class="external text external">1QVN</a>, <a href="javascript:if(confirm('https://www.rcsb.org/structure/1Z92  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/1Z92'" tppabs="https://www.rcsb.org/structure/1Z92" class="external text external">1Z92</a>, <a href="javascript:if(confirm('https://www.rcsb.org/structure/2B5I  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/2B5I'" tppabs="https://www.rcsb.org/structure/2B5I" class="external text external">2B5I</a>, <a href="javascript:if(confirm('https://www.rcsb.org/structure/2ERJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/2ERJ'" tppabs="https://www.rcsb.org/structure/2ERJ" class="external text external">2ERJ</a>, <a href="javascript:if(confirm('https://www.rcsb.org/structure/3QAZ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/3QAZ'" tppabs="https://www.rcsb.org/structure/3QAZ" class="external text external">3QAZ</a>, <a href="javascript:if(confirm('https://www.rcsb.org/structure/3QB1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/3QB1'" tppabs="https://www.rcsb.org/structure/3QB1" class="external text external">3QB1</a>, <a href="javascript:if(confirm('https://www.rcsb.org/structure/3INK  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/3INK'" tppabs="https://www.rcsb.org/structure/3INK" class="external text external">3INK</a>, <a href="javascript:if(confirm('https://www.rcsb.org/structure/4NEJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/4NEJ'" tppabs="https://www.rcsb.org/structure/4NEJ" class="external text external">4NEJ</a>, <a href="javascript:if(confirm('https://www.rcsb.org/structure/4NEM  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rcsb.org/structure/4NEM'" tppabs="https://www.rcsb.org/structure/4NEM" class="external text external">4NEM</a></span></p></td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th colspan="4" style="text-align:center;background-color:#ddd">Identifiers</th></tr><tr><th scope="row" style="background-color:#c3fdb8"><span class="">Aliases</span></th><td colspan="3" style="background:#eee"><span class=""><a href="javascript:if(confirm('https://www.genenames.org/data/gene-symbol-report/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/6001'" tppabs="https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/6001" class="external text external">IL2</a></span>, IL-2, TCGF, lymphokine, interleukin 2</td></tr><tr><th scope="row" style="background-color:#c3fdb8">External IDs</th><td colspan="3" style="background-color:#eee"><span class="">OMIM: <a href="javascript:if(confirm('https://omim.org/entry/147680  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://omim.org/entry/147680'" tppabs="https://omim.org/entry/147680" class="external text external">147680</a> MGI: <a href="javascript:if(confirm('http://www.informatics.jax.org/marker/MGI:96548  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.informatics.jax.org/marker/MGI:96548'" tppabs="http://www.informatics.jax.org/marker/MGI:96548" class="external text external">96548</a> HomoloGene: <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=homologene&dopt=HomoloGene&list_uids=488  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=homologene&dopt=HomoloGene&list_uids=488'" tppabs="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=homologene&dopt=HomoloGene&list_uids=488" class="external text external">488</a> GeneCards: <a href="javascript:if(confirm('https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL2'" tppabs="https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL2" class="external text external">IL2</a> </span></td></tr><tr><td colspan="4" style="text-align:center;background-color:#eee"><table class="collapsible expand" style="padding:0;border:none;margin:0;width:100%;text-align:left"><tbody><tr><th colspan="4" style="text-align:center;background-color:#ddd">Gene location (Human)</th></tr><tr><td colspan="4" style="text-align:center;background-color:#eee"><figure-inline><img src="../I/m/Ideogram_human_chromosome_4.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Ideogram_human_chromosome_4.svg.png" data-file-width="474" data-file-height="189" data-file-type="drawing" height="120" width="300"></figure-inline></td></tr><tr><th scope="row" width="15%" style="background-color:#c3fdb8">Chr.</th><td colspan="3" width="85%" style="background-color:#eee"><span class="">Chromosome 4 (human)<span class="mw-ref" id="cite_ref-refGRCh38Ensembl_1-0"><a href="#cite_note-refGRCh38Ensembl-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></span></td></tr><tr><td colspan="4" style="text-align:center;background-color:#eee"><div align="center"><div style="position: relative; width: 300px;"><figure-inline><img src="../I/m/Human_chromosome_4_ideogram.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Human_chromosome_4_ideogram.svg.png" data-file-width="1125" data-file-height="216" data-file-type="drawing" height="58" width="300"></figure-inline><div style="position: absolute; left: 183.95362517756px; top: 2px; padding: 0;"><figure-inline><img src="../I/m/HSR_1996_II_3.5e.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/HSR_1996_II_3.5e.svg.png" data-file-width="142" data-file-height="142" data-file-type="drawing" height="14" width="14"></figure-inline></div><div style="position: absolute; left: 190px; top: 19px; padding: 0;"><figure-inline><img src="../I/m/Red_rectangle_2x18.png" tppabs="https://ptable.com/wiki/compounds/I/m/Red_rectangle_2x18.png" data-file-width="2" data-file-height="18" data-file-type="bitmap" height="18" width="2"></figure-inline></div></div></div></td></tr><tr><th scope="row" rowspan="2" width="15%" style="background-color:#c3fdb8">Band</th><td rowspan="2" width="35%" style="background-color:#eee"><span class="">4q27</span></td><th scope="row" style="background-color:#c3fdb8">Start</th><td style="background-color:#eee"><span class="">122,451,470 bp<span class="mw-ref" id="cite_ref-refGRCh38Ensembl_1-1"><a href="#cite_note-refGRCh38Ensembl-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></span></td></tr><tr><th scope="row" style="background-color:#c3fdb8">End</th><td style="background-color:#eee"><span class="">122,456,725 bp<span class="mw-ref" id="cite_ref-refGRCh38Ensembl_1-2"><a href="#cite_note-refGRCh38Ensembl-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></span></td></tr></tbody></table></td></tr><tr><td colspan="4" style="text-align:center;background-color:#eee"><table class="collapsible collapsed" style="padding:0;border:none;margin:0;width:100%;text-align:left"><tbody><tr><th colspan="4" style="text-align:center;background-color:#ddd">Gene location (Mouse)</th></tr><tr><td colspan="4" style="text-align:center;background-color:#eee"><figure-inline><img src="../I/m/Ideogram_house_mouse_chromosome_3.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Ideogram_house_mouse_chromosome_3.svg.png" data-file-width="470" data-file-height="200" data-file-type="drawing" height="111" width="260"></figure-inline></td></tr><tr><th scope="row" width="15%" style="background-color:#c3fdb8">Chr.</th><td colspan="3" width="85%" style="background-color:#eee"><span class="">Chromosome 3 (mouse)<span class="mw-ref" id="cite_ref-refGRCm38Ensembl_2-0"><a href="#cite_note-refGRCm38Ensembl-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></span></td></tr><tr><td colspan="4" style="text-align:center;background-color:#eee"><div align="center"><div style="position: relative; width: 300px;"><figure-inline><img src="../I/m/Ideogram_of_house_mouse_chromosome_3.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Ideogram_of_house_mouse_chromosome_3.svg.png" data-file-width="1200" data-file-height="231" data-file-type="drawing" height="58" width="300"></figure-inline><div style="position: absolute; left: 62.827939906536px; top: 2px; padding: 0;"><figure-inline><img src="../I/m/HSR_1996_II_3.5e.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/HSR_1996_II_3.5e.svg.png" data-file-width="142" data-file-height="142" data-file-type="drawing" height="14" width="14"></figure-inline></div><div style="position: absolute; left: 68.8px; top: 19px; padding: 0;"><figure-inline><img src="../I/m/Red_rectangle_2x18.png" tppabs="https://ptable.com/wiki/compounds/I/m/Red_rectangle_2x18.png" data-file-width="2" data-file-height="18" data-file-type="bitmap" height="18" width="2"></figure-inline></div></div></div></td></tr><tr><th scope="row" rowspan="2" width="15%" style="background-color:#c3fdb8">Band</th><td rowspan="2" width="35%" style="background-color:#eee"><span class="">3 B<span>|</span>3 18.3 cM</span></td><th scope="row" style="background-color:#c3fdb8">Start</th><td style="background-color:#eee"><span class="">37,120,523 bp<span class="mw-ref" id="cite_ref-refGRCm38Ensembl_2-1"><a href="#cite_note-refGRCm38Ensembl-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></span></td></tr><tr><th scope="row" style="background-color:#c3fdb8">End</th><td style="background-color:#eee"><span class="">37,125,959 bp<span class="mw-ref" id="cite_ref-refGRCm38Ensembl_2-2"><a href="#cite_note-refGRCm38Ensembl-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></span></td></tr></tbody></table></td></tr><tr><td colspan="4" style="text-align:center;background-color:#eee"><table class="collapsible expand" style="padding:0;border:none;margin:0;width:100%;text-align:left"><tbody><tr><th colspan="4" style="text-align:center;background-color:#ddd">RNA expression pattern</th></tr><tr><td colspan="4" style="text-align:center;background-color:#eee"><figure-inline><img src="../I/m/PBB_GE_IL2_207849_at_fs.png" tppabs="https://ptable.com/wiki/compounds/I/m/PBB_GE_IL2_207849_at_fs.png" data-file-width="732" data-file-height="530" data-file-type="bitmap" height="181" width="250"></figure-inline></td></tr><tr><td colspan="4" style="text-align:center;background-color:#eee"><span class=""><a href="javascript:if(confirm('http://biogps.org/gene/3558/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://biogps.org/gene/3558/'" tppabs="http://biogps.org/gene/3558/" class="external text external">More reference expression data</a></span></td></tr></tbody></table></td></tr><tr><td colspan="4" style="text-align:center;background-color:#eee"><table class="collapsible collapsed" style="padding:0;border:none;margin:0;width:100%;text-align:left"><tbody><tr><th colspan="4" style="text-align:center;background-color:#ddd">Gene ontology</th></tr><tr><th style="background-color:#c3fdb8">Molecular function</th><td style="background-color:#eee"><span class=""><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0005125  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0005125'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0005125" class="external text external">cytokine activity</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0005134  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0005134'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0005134" class="external text external">interleukin-2 receptor binding</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0043208  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0043208'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0043208" class="external text external">glycosphingolipid binding</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0019209  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0019209'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0019209" class="external text external">kinase activator activity</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0008083  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0008083'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0008083" class="external text external">growth factor activity</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0031851  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0031851'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0031851" class="external text external">kappa-type opioid receptor binding</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0030246  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0030246'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0030246" class="external text external">carbohydrate binding</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0005088  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0005088'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0005088" class="external text external">Ras guanyl-nucleotide exchange factor activity</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0005515,  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0005515,'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0005515," class="external text external">GO:0001948 protein binding</a><br></span></td></tr><tr><th style="background-color:#c3fdb8">Cellular component</th><td style="background-color:#eee"><span class=""><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0005576  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0005576'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0005576" class="external text external">extracellular region</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0005623  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0005623'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0005623" class="external text external">cell</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0005622  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0005622'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0005622" class="external text external">intracellular</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0005615  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0005615'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0005615" class="external text external">extracellular</a><br></span></td></tr><tr><th style="background-color:#c3fdb8">Biological process</th><td style="background-color:#eee"><span class=""><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0045582  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0045582'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0045582" class="external text external">positive regulation of T cell differentiation</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0001933  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0001933'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0001933" class="external text external">negative regulation of protein phosphorylation</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0007186  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0007186'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0007186" class="external text external">G-protein coupled receptor signaling pathway</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0001934  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0001934'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0001934" class="external text external">positive regulation of protein phosphorylation</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0050729  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0050729'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0050729" class="external text external">positive regulation of inflammatory response</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0002250  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0002250'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0002250" class="external text external">adaptive immune response</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0045822  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0045822'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0045822" class="external text external">negative regulation of heart contraction</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0002376  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0002376'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0002376" class="external text external">immune system process</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0007204  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0007204'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0007204" class="external text external">positive regulation of cytosolic calcium ion concentration</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0045591  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0045591'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0045591" class="external text external">positive regulation of regulatory T cell differentiation</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0007267  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0007267'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0007267" class="external text external">cell-cell signaling</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0032729  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0032729'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0032729" class="external text external">positive regulation of interferon-gamma production</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0030101  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0030101'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0030101" class="external text external">natural killer cell activation</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0043066  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0043066'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0043066" class="external text external">negative regulation of apoptotic process</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0060999  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0060999'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0060999" class="external text external">positive regulation of dendritic spine development</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0050672  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0050672'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0050672" class="external text external">negative regulation of lymphocyte proliferation</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0000165  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0000165'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0000165" class="external text external">MAPK cascade</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0046013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0046013'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0046013" class="external text external">regulation of T cell homeostatic proliferation</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0030217  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0030217'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0030217" class="external text external">T cell differentiation</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0030307  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0030307'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0030307" class="external text external">positive regulation of cell growth</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0007205  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0007205'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0007205" class="external text external">protein kinase C-activating G-protein coupled receptor signaling pathway</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0007155  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0007155'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0007155" class="external text external">cell adhesion</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0030890  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0030890'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0030890" class="external text external">positive regulation of B cell proliferation</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0034105  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0034105'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0034105" class="external text external">positive regulation of tissue remodeling</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0042102  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0042102'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0042102" class="external text external">positive regulation of T cell proliferation</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0006955  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0006955'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0006955" class="external text external">immune response</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0008284  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0008284'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0008284" class="external text external">positive regulation of cell proliferation</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0097192  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0097192'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0097192" class="external text external">extrinsic apoptotic signaling pathway in absence of ligand</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0002903  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0002903'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0002903" class="external text external">negative regulation of B cell apoptotic process</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0048304  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0048304'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0048304" class="external text external">positive regulation of isotype switching to IgG isotypes</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0032740  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0032740'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0032740" class="external text external">positive regulation of interleukin-17 production</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0045471  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0045471'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0045471" class="external text external">response to ethanol</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0051024  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0051024'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0051024" class="external text external">positive regulation of immunoglobulin secretion</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0050728  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0050728'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0050728" class="external text external">negative regulation of inflammatory response</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0045944  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0045944'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0045944" class="external text external">positive regulation of transcription from RNA polymerase II promoter</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0042104  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0042104'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0042104" class="external text external">positive regulation of activated T cell proliferation</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:2000320  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:2000320'" tppabs="http://amigo.geneontology.org/amigo/term/GO:2000320" class="external text external">negative regulation of T-helper 17 cell differentiation</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0002366  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0002366'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0002366" class="external text external">leukocyte activation involved in immune response</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0042531  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0042531'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0042531" class="external text external">positive regulation of tyrosine phosphorylation of STAT protein</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0045589  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0045589'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0045589" class="external text external">regulation of regulatory T cell differentiation</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0010469  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0010469'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0010469" class="external text external">regulation of receptor activity</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0019221  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0019221'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0019221" class="external text external">cytokine-mediated signaling pathway</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0038110  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0038110'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0038110" class="external text external">interleukin-2-mediated signaling pathway</a><br><big>•</big> <a href="javascript:if(confirm('http://amigo.geneontology.org/amigo/term/GO:0033674  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/amigo/term/GO:0033674'" tppabs="http://amigo.geneontology.org/amigo/term/GO:0033674" class="external text external">positive regulation of kinase activity</a><br></span></td></tr><tr><td colspan="4" style="background-color:#eee;text-align:center">Sources:<a href="javascript:if(confirm('http://amigo.geneontology.org/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://amigo.geneontology.org/'" tppabs="http://amigo.geneontology.org/" class="external text external">Amigo</a> / <a href="javascript:if(confirm('https://www.ebi.ac.uk/QuickGO/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/QuickGO/'" tppabs="https://www.ebi.ac.uk/QuickGO/" class="external text external">QuickGO</a></td></tr></tbody></table></td></tr><tr><th colspan="4" style="text-align:center;background-color:#ddd">Orthologs</th></tr><tr><th scope="row" style="background-color:#c3fdb8">Species</th><td><b>Human</b></td><td><b>Mouse</b></td></tr><tr><th scope="row" style="background-color:#c3fdb8">Entrez</th><td><table class="none" style="padding:0;border:none;margin:0;width:100%;text-align:right"><tbody><tr><th colspan="1"></th></tr><tr><td colspan="1"><p class=""><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=retrieve&dopt=default&list_uids=3558&rn=1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=retrieve&dopt=default&list_uids=3558&rn=1'" tppabs="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=retrieve&dopt=default&list_uids=3558&rn=1" class="external text external">3558</a></p></td></tr></tbody></table></td><td><table class="none" style="padding:0;border:none;margin:0;width:100%;text-align:right"><tbody><tr><th colspan="1"></th></tr><tr><td colspan="1"><p class=""><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=retrieve&dopt=default&list_uids=16183&rn=1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=retrieve&dopt=default&list_uids=16183&rn=1'" tppabs="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=retrieve&dopt=default&list_uids=16183&rn=1" class="external text external">16183</a></p></td></tr></tbody></table></td></tr><tr><th scope="row" style="background-color:#c3fdb8">Ensembl</th><td><table class="none" style="padding:0;border:none;margin:0;width:100%;text-align:right"><tbody><tr><th colspan="1"></th></tr><tr><td colspan="1"><p class=""><a href="javascript:if(confirm('http://www.ensembl.org/Homo_sapiens/geneview?gene=ENSG00000109471;db=core  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ensembl.org/Homo_sapiens/geneview?gene=ENSG00000109471;db=core'" tppabs="http://www.ensembl.org/Homo_sapiens/geneview?gene=ENSG00000109471;db=core" class="external text external">ENSG00000109471</a></p></td></tr></tbody></table></td><td><table class="none" style="padding:0;border:none;margin:0;width:100%;text-align:right"><tbody><tr><th colspan="1"></th></tr><tr><td colspan="1"><p class=""><a href="javascript:if(confirm('http://www.ensembl.org/Mus_musculus/geneview?gene=ENSMUSG00000027720;db=core  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ensembl.org/Mus_musculus/geneview?gene=ENSMUSG00000027720;db=core'" tppabs="http://www.ensembl.org/Mus_musculus/geneview?gene=ENSMUSG00000027720;db=core" class="external text external">ENSMUSG00000027720</a></p></td></tr></tbody></table></td></tr><tr><th scope="row" style="background-color:#c3fdb8">UniProt</th><td><table class="none" style="padding:0;border:none;margin:0;width:100%;text-align:right"><tbody><tr><th colspan="1"></th></tr><tr><td colspan="1"><p class=""><a href="javascript:if(confirm('https://www.uniprot.org/uniprot/P60568  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.uniprot.org/uniprot/P60568'" tppabs="https://www.uniprot.org/uniprot/P60568" class="external text external">P60568</a></p></td></tr></tbody></table></td><td><table style="padding:0;border:none;margin:0;width:100%;text-align:right"><tbody><tr><th colspan="1"></th></tr><tr><td colspan="1"><p class=""><a href="javascript:if(confirm('https://www.uniprot.org/uniprot/P04351  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.uniprot.org/uniprot/P04351'" tppabs="https://www.uniprot.org/uniprot/P04351" class="external text external">P04351</a></p></td></tr></tbody></table></td></tr><tr><th scope="row" style="background-color:#c3fdb8">RefSeq (mRNA)</th><td><table class="none" style="padding:0;border:none;margin:0;width:100%;text-align:right"><tbody><tr><th colspan="1" class=""></th></tr><tr><td colspan="1"><p><span class=""><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_000586  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_000586'" tppabs="https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_000586" class="external text external">NM_000586</a></span></p></td></tr></tbody></table></td><td><table class="none" style="padding:0;border:none;margin:0;width:100%;text-align:right"><tbody><tr><th colspan="1" class=""></th></tr><tr><td colspan="1"><p><span class=""><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_008366  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_008366'" tppabs="https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_008366" class="external text external">NM_008366</a></span></p></td></tr></tbody></table></td></tr><tr><th scope="row" style="background-color:#c3fdb8">RefSeq (protein)</th><td><table class="none" style="padding:0;border:none;margin:0;width:100%;text-align:right"><tbody><tr><th colspan="1" class=""></th></tr><tr><td colspan="1"><p><span class=""><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_000577  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_000577'" tppabs="https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_000577" class="external text external">NP_000577</a></span></p></td></tr></tbody></table></td><td><table class="none" style="padding:0;border:none;margin:0;width:100%;text-align:right"><tbody><tr><th colspan="1" class=""></th></tr><tr><td colspan="1"><p><span class=""><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_032392  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_032392'" tppabs="https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_032392" class="external text external">NP_032392</a></span></p></td></tr></tbody></table></td></tr><tr><th scope="row" style="background-color:#c3fdb8">Location (UCSC)</th><td><span class=""><a href="javascript:if(confirm('https://genome.ucsc.edu/cgi-bin/hgTracks?org=Human&db=hg38&position=chr4:122451470-122456725  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://genome.ucsc.edu/cgi-bin/hgTracks?org=Human&db=hg38&position=chr4:122451470-122456725'" tppabs="https://genome.ucsc.edu/cgi-bin/hgTracks?org=Human&db=hg38&position=chr4:122451470-122456725" class="external text external">Chr 4: 122.45 – 122.46 Mb</a></span></td><td><span class=""><a href="javascript:if(confirm('https://genome.ucsc.edu/cgi-bin/hgTracks?org=Mouse&db=mm0&position=chr3:37120523-37125959  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://genome.ucsc.edu/cgi-bin/hgTracks?org=Mouse&db=mm0&position=chr3:37120523-37125959'" tppabs="https://genome.ucsc.edu/cgi-bin/hgTracks?org=Mouse&db=mm0&position=chr3:37120523-37125959" class="external text external">Chr 3: 37.12 – 37.13 Mb</a></span></td></tr><tr><th scope="row" style="background-color:#c3fdb8">PubMed search</th><td><span class=""><span class="mw-ref" id="cite_ref-3"><a href="#cite_note-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></span></td><td><span class=""><span class="mw-ref" id="cite_ref-4"><a href="#cite_note-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></span></td></tr><tr><td colspan="4" style="text-align:center;font-size:x-small;background-color:#eee">Wikidata</td></tr><tr><td colspan="4" style="text-align:center;font-size:x-small;background-color:#eee"><table style="padding:0;border:none;margin:0;width:100%;text-align:center"><tbody><tr><td colspan="2" style="background-color:#eee;text-align:center;font-size:x-small"><a href="javascript:if(confirm('https://www.wikidata.org/wiki/Q14864515  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wikidata.org/wiki/Q14864515'" tppabs="https://www.wikidata.org/wiki/Q14864515" title="d:Q14864515" class="external">View/Edit Human</a></td><td colspan="2" style="background-color:#eee;text-align:center;font-size:x-small"><a href="javascript:if(confirm('https://www.wikidata.org/wiki/Q14864516  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wikidata.org/wiki/Q14864516'" tppabs="https://www.wikidata.org/wiki/Q14864516" title="d:Q14864516" class="external">View/Edit Mouse</a></td></tr></tbody></table></td></tr></tbody></table>

</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="IL-2_receptor">IL-2 receptor</h2></summary>
    

<p>IL-2 is a member of a cytokine family, each member of which has a four alpha helix bundle; the family also includes IL-4, IL-7, IL-9, IL-15 and IL-21. IL-2 signals through the IL-2 receptor, a complex consisting of three chains, termed alpha (CD25), beta (CD122) and gamma (CD132). The gamma chain is shared by all family members.<span class="mw-ref" id="cite_ref-Liao_2011_6-1"><a href="#cite_note-Liao_2011-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>

<p>The IL-2 receptor (IL-2R) α subunit binds IL-2 with low affinity (K<sub>d</sub>~ 10<sup>−8</sup> M). Interaction of IL-2 and CD25 alone does not lead to signal transduction due to its short intracellular chain but has the ability (when bound to the β and γ subunit) to increase the IL-2R affinity 100-fold.<span class="mw-ref" id="cite_ref-:1_7-0"><a href="#cite_note-:1-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-:0_5-1"><a href="#cite_note-:0-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Heterodimerization of the β and γ subunits of IL-2R is essential for signalling in T cells.<span class="mw-ref" id="cite_ref-Gaffen_2004_8-0"><a href="#cite_note-Gaffen_2004-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> IL-2 can signalize either via intermediate-affinity dimeric CD122/CD132 IL-2R (K<sub>d</sub>~ 10<sup>−9</sup> M) or high-affinity trimeric CD25/CD122/CD132 IL-2R (K<sub>d</sub>~ 10<sup>−11</sup> M).<span class="mw-ref" id="cite_ref-:1_7-1"><a href="#cite_note-:1-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Dimeric IL-2R is expressed by memory CD8<sup>+</sup> T cells and NK cells, whereas regulatory T cells and activated T cells express high levels of trimeric IL-2R.<span class="mw-ref" id="cite_ref-:0_5-2"><a href="#cite_note-:0-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="IL-2_signaling_pathways_and_regulation">IL-2 signaling pathways and regulation</h2></summary>
    
<p>The pleiotropic effects of IL-2 are enabled due to the fact that IL-2 signal can be transduced via 3 different signaling pathways; JAK-STAT, PI3K/Akt/mTOR and MAPK/ERK pathway.<span class="mw-ref" id="cite_ref-:0_5-3"><a href="#cite_note-:0-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> After IL-2 binding to its receptor, cytoplasmatic domains of CD122 and CD132 heterodimerize. This leads to the activation of Janus kinases JAK1 and JAK3 which subsequently phosphorylate <a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine">T338</a> on CD122. This phosphorylation recruits STAT transcription factors, predominantly STAT5, which dimerize and migrate to the cell nucleus where they bind to DNA.<span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>

<p>Gene expression regulation for IL-2 can be on multiple levels or by different ways. One of the checkpoints is signaling through TCR, antigen receptor of T-lymphocytes after recognizing MHC-peptide complex. Signaling pathway from TCR then goes through phospholipase-C (PLC) dependent pathway. PLC activates 3 major transcription factors and their pathways: NFAT, NFkB and AP-1. After costimulation from CD28 the optimal activation of expression of IL-2 and these pathways is induced.</p>

<p>At the same time Oct-1 is expressed. It helps the activation. Oct1 is expressed in T-lymphocytes and Oct2 is induced after cell activation.</p>

<p><b>NFAT</b> has multiple family members, all of them are located in cytoplasm and signaling goes through calcineurin, NFAT is dephosphorylated and therefore translocated to the nucleus.</p>

<p><b>AP-1</b> is a dimer and is composed of c-Jun and c-Fos proteins. It cooperates with other transcription factors including NFkB and Oct.</p>

<p><b>NFkB</b> is translocated to the nucleus after costimulation through CD28. NFkB is a heterodimer and there are two binding sites on the IL-2 promoter.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Function">Function</h2></summary>
    

<p>IL-2 has essential roles in key functions of the immune system, tolerance and immunity, primarily via its direct effects on T cells. In the thymus, where T cells mature, it prevents autoimmune diseases by promoting the differentiation of certain immature T cells into regulatory T cells, which suppress other T cells that are otherwise primed to attack normal healthy cells in the body. IL-2 enhances activation-induced cell death (AICD).<span class="mw-ref" id="cite_ref-:0_5-4"><a href="#cite_note-:0-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> IL-2 also promotes the differentiation of T cells into effector T cells and into memory T cells when the initial T cell is also stimulated by an antigen, thus helping the body fight off infections.<span class="mw-ref" id="cite_ref-Liao_2011_6-2"><a href="#cite_note-Liao_2011-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Together with other polarizing cytokines, IL-2 stimulates naive CD4<sup>+</sup> T cell differentiation into Th1 and Th2 lymphocytes while it impedes differentiation into Th17 and folicular Th lymphocytes.<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<p>Its expression and secretion is tightly regulated and functions as part of both transient positive and negative feedback loops in mounting and dampening immune responses. Through its role in the development of T cell immunologic memory, which depends upon the expansion of the number and function of antigen-selected T cell clones, it plays a key role in enduring cell-mediated immunity.<span class="mw-ref" id="cite_ref-Liao_2011_6-3"><a href="#cite_note-Liao_2011-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Malek_2010_11-0"><a href="#cite_note-Malek_2010-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Role_in_disease">Role in disease</h2></summary>
    

<p>While the causes of itchiness are poorly understood, some evidence indicates that IL-2 is involved in itchy psoriasis.<span class="mw-ref" id="cite_ref-pmid18288273_12-0"><a href="#cite_note-pmid18288273-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_use">Medical use</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmaceutical_analogues">Pharmaceutical analogues</h3></summary>
    
<p>Aldesleukin is a form of recombinant interleukin-2. It is manufactured using recombinant DNA technology and is marketed as a protein therapeutic and branded as Proleukin. It has been approved by the Food and Drug Administration (FDA) and in several European countries for the treatment of cancers (malignant melanoma, renal cell cancer) in large intermittent doses and has been extensively used in continuous doses.<span class="mw-ref" id="cite_ref-pmid18031103_13-0"><a href="#cite_note-pmid18031103-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-pmid19544689_14-0"><a href="#cite_note-pmid19544689-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-Pollack_1990_15-0"><a href="#cite_note-Pollack_1990-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>

<p>Interking is a recombinant IL-2 with a <a href="Serine.htm" tppabs="https://ptable.com/wiki/compounds/A/Serine" title="Serine">serine</a> at residue 125, sold by Shenzhen Neptunus.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>

<p>Neoleukin 2/15 is a computationally designed mimic of IL-2 that was designed to avoid common side effects.<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> It is currently being commercialized into a therapeutic.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Dosage">Dosage</h4></summary>
    
<p>Various dosages of IL-2 across the United States and across the world are used. The efficacy and side effects of different dosages is often a point of disagreement.</p>

<p>The commercial interest in local IL-2 therapy has been very low. Because only a very low dose IL-2 is used, treatment of a patient would cost about $ 500 commercial value of the patented IL-2. The commercial return on investment is too low to stimulate additional clinical studies for the registration of intratumoral IL-2 therapy.</p>


</details>
<details data-level="5" open="">
    <summary class="section-heading"><h5 id="United_States">United States</h5></summary>
    
<p>Usually, in the U.S., the higher dosage option is used, affected by cancer type, response to treatment and general patient health. Patients are typically treated for five consecutive days, three times a day, for fifteen minutes. The following approximately 10 days help the patient to recover between treatments. IL-2 is delivered intravenously on an inpatient basis to enable proper monitoring of side effects.<span class="mw-ref" id="cite_ref-American_Cancer_Society_19-0"><a href="#cite_note-American_Cancer_Society-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>

<p>A lower dose regimen involves injection of IL-2 under the skin typically on an outpatient basis. It may alternatively be given on an inpatient basis over 1–3 days, similar to and often including the delivery of chemotherapy.<span class="mw-ref" id="cite_ref-American_Cancer_Society_19-1"><a href="#cite_note-American_Cancer_Society-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>

<p>Intralesional IL-2 is commonly used to treat in-transit melanoma metastases and has a high complete response rate.<span class="mw-ref" id="cite_ref-Intralesional_IL_2_20-0"><a href="#cite_note-Intralesional_IL_2-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Local_application">Local application</h4></summary>
    
<p>In preclinical and early clinical studies, local application of IL-2 in the tumor has been shown to be clinical more effective in anticancer therapy than systemic IL-2 therapy, over a broad range of doses, without serious side effects.<span class="mw-ref" id="cite_ref-pmid18256831_21-0"><a href="#cite_note-pmid18256831-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></p>

<p>Tumour blood vessels are more vulnerable than normal blood vessels to the actions of IL-2. When injected inside a tumor, i.e. local application, a process mechanistically similar to the vascular leakage syndrome, occurs in tumor tissue only. Disruption of the blood flow inside of the tumor effectively destroy tumor tissue.<span class="mw-ref" id="cite_ref-pmid15685449_22-0"><a href="#cite_note-pmid15685449-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></p>

<p>In local application, the systemic dose of IL-2 is too low to cause side effects, since the total dose is about 100 to 1000 fold lower. Clinical studies showed painful injections at the site of radiation as the most important side effect, reported by patients. In the case of irradiation of nasopharyngeal carcinoma the five-year disease-free survival increased from 8% to 63% by local IL-2 therapy <span class="mw-ref" id="cite_ref-pmid15627211_23-0"><a href="#cite_note-pmid15627211-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Toxicity">Toxicity</h4></summary>
    
<p>Systemic IL-2 has a narrow therapeutic window, and the level of dosing usually determines the severity of the side effects.<span class="mw-ref" id="cite_ref-pmid19009549_24-0"><a href="#cite_note-pmid19009549-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> In the case of local IL-2 application, the therapeutic window spans several orders of magnitude.<span class="mw-ref" id="cite_ref-pmid18256831_21-1"><a href="#cite_note-pmid18256831-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></p>

<p>Some common side effects:<span class="mw-ref" id="cite_ref-American_Cancer_Society_19-2"><a href="#cite_note-American_Cancer_Society-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>
<ul><li>flu-like symptoms (fever, headache, muscle and joint pain, fatigue)</li>
<li>nausea/vomiting</li>
<li>dry, itchy skin or rash</li>
<li>weakness or shortness of breath</li>
<li>diarrhea</li>
<li>low blood pressure</li>
<li>drowsiness or confusion</li>
<li>loss of appetite</li></ul>

<p>More serious and dangerous side effects sometimes are seen, such as breathing problems, serious infections, seizures, allergic reactions, heart problems, kidney failure or a variety of other possible complications.<span class="mw-ref" id="cite_ref-American_Cancer_Society_19-3"><a href="#cite_note-American_Cancer_Society-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> The most common adverse effect of high-dose IL-2 therapy is vascular leak syndrome (VLS; also termed capillary leak syndrome). It is caused by lung endothelial cells expressing high-affinity IL-2R. These cells, as a result of IL-2 binding, causes increased vascular permeability. Thus, intravascular fluid extravasate into organs, predominantly lungs, which leads to life-threatening pulmonary or brain oedema.<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>

<p>Other drawbacks of IL-2 cancer immunotherapy are its short half-life in circulation and its ability to predominantly expand regulatory T cells at high doses.<span class="mw-ref" id="cite_ref-:0_5-5"><a href="#cite_note-:0-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-Liao_2011_6-4"><a href="#cite_note-Liao_2011-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>

<p>Intralesional IL-2 used to treat in-transit melanoma metastases is generally well tolerated.<span class="mw-ref" id="cite_ref-Intralesional_IL_2_20-1"><a href="#cite_note-Intralesional_IL_2-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> This is also the case for intralesional IL-2 in other forms of cancer, like nasopharyngeal carcinoma.<span class="mw-ref" id="cite_ref-pmid15627211_23-1"><a href="#cite_note-pmid15627211-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmaceutical_derivative">Pharmaceutical derivative</h3></summary>
    
<p>Eisai markets a drug called <a href="Denileukin_diftitox.htm" tppabs="https://ptable.com/wiki/compounds/A/Denileukin_diftitox" title="Denileukin diftitox">denileukin diftitox</a> (trade name Ontak), which is a recombinant fusion protein of the human IL-2 ligand and the diphtheria toxin.<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> This drug binds to IL-2 receptors and introduces the diphtheria toxin into cells that express those receptors, killing the cells. In some leukemias and lymphomas, malignant cells express the IL-2 receptor, so denileukin diftitox can kill them. In 1999 Ontak was approved by the U.S. Food and Drug Administration (FDA) for treatment of cutaneous T cell lymphoma (CTCL).<span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Preclinical_research">Preclinical research</h2></summary>
    
<p>IL-2 does not follow the classical dose-response curve of chemotherapeutics. The immunological activity of high and low dose IL-2 show sharp contrast. This might be related to different distribution of IL-2 receptors (CD25, CD122, CD132) on different cell populations, resulting in different cells that are activated by high and low dose IL-2. In general high doses are immune suppressive, while low doses can stimulate type 1 immunity.<span class="mw-ref" id="cite_ref-28"><a href="#cite_note-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> Low-dose IL-2 has been reported to reduce hepatitis C and B infection.<span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>

<p>IL-2 has been used in clinical trials for the treatment of chronic viral infections and as a booster (adjuvant) for vaccines. The use of large doses of IL-2 given every 6–8 weeks in HIV therapy, similar to its use in cancer therapy, was found to be ineffective in preventing progression to an AIDS diagnosis in two large clinical trials published in 2009.<span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>

<p>More recently low dose IL-2 has shown early success in modulating the immune system in disease like type 1 diabetes and vasculitis.<span class="mw-ref" id="cite_ref-31"><a href="#cite_note-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> There are also promising studies looking to use low dose IL-2 in ischaemic heart disease.<span class="mw-ref" id="cite_ref-32"><a href="#cite_note-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="IL-2/anti-IL-2_mAb_immune_complexes_(IL-2_ic)">IL-2/anti-IL-2 mAb immune complexes (IL-2 ic)</h3></summary>
    
<p>IL-2 cannot accomplish its role as a promising immunotherapeutic agent due to significant drawbacks which are listed above. Some of the issues can be overcome using IL-2 ic. They are composed of IL-2 and some of its monoclonal antibody (mAb) and can potentiate biologic activity of IL-2 <i>in vivo</i>. The main mechanism of this phenomenon <i>in vivo</i> is due to the prolongation of the cytokine half-life in circulation. Depending on the clone of IL-2 mAb, IL-2 ic  can selectively stimulate either CD25<sup>high</sup> (IL-2/JES6-1 complexes), or CD122<sup>high</sup> cells (IL-2/S4B6). IL-2/S4B6 immune complexes have high stimulatory activity for NK cells and memory CD8<sup>+</sup> T cells and they could thus replace the conventional IL-2 in cancer immunotherapy. On the other hand, IL-2/JES6-1 highly selectively stimulate regulatory T cells and they could be potentially useful for transplantations and in treatment of autoimmune diseases.<span class="mw-ref" id="cite_ref-33"><a href="#cite_note-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><span class="mw-ref" id="cite_ref-:0_5-6"><a href="#cite_note-:0-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    

<p>According to an immunology textbook: "IL-2 is particularly important historically, as it is the first type I cytokine that was cloned, the first type I cytokine for which a receptor component was cloned, and was the first short-chain type I cytokine whose receptor structure was solved. Many general principles have been derived from studies of this cytokine including its being the first cytokine demonstrated to act in a growth factor–like fashion through specific high-affinity receptors, analogous to the growth factors being studied by endocrinologists and biochemists".<span class="mw-ref" id="cite_ref-Leonard_34-0"><a href="#cite_note-Leonard-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>712</span></sup></p>

<p>In the mid-1960s, studies reported "activities" in leukocyte-conditioned media that promoted lymphocyte proliferation.<span class="mw-ref" id="cite_ref-pmid20074271_35-0"><a href="#cite_note-pmid20074271-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>16</span></sup> In the mid-1970s, it was discovered that T-cells could be selectively proliferated when normal human bone marrow cells were cultured in conditioned medium obtained from phytohemagglutinin-stimulated normal human lymphocytes.<span class="mw-ref" id="cite_ref-Leonard_34-1"><a href="#cite_note-Leonard-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>712</span></sup> The key factor was isolated from cultured mouse cells in 1979 and from cultured human cells in 1980.<span class="mw-ref" id="cite_ref-pmid6980256_36-0"><a href="#cite_note-pmid6980256-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span> The gene for human IL-2 was cloned in 1982 after an intense competition.<span class="mw-ref" id="cite_ref-CetusHist_37-0"><a href="#cite_note-CetusHist-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>76</span></sup></p>

<p>Commercial activity to bring an IL-2 drug to market was intense in the 1980s and '90s. By 1983, Cetus Corporation had created a proprietary recombinant version of IL-2 (Aldesleukin, later branded as Proleukin), with the <a href="Alanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alanine" title="Alanine">alanine</a> removed from its N-terminal and residue 125 replaced with serine.<span class="mw-ref" id="cite_ref-CetusHist_37-1"><a href="#cite_note-CetusHist-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>76–77</span></sup><span class="mw-ref" id="cite_ref-38"><a href="#cite_note-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>201</span></sup><span class="mw-ref" id="cite_ref-Whittington_1993_39-0"><a href="#cite_note-Whittington_1993-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span> Amgen later entered the field with its own proprietary, mutated, recombinant protein and Cetus and Amgen were soon competing scientifically and in the courts; Cetus won the legal battles and forced Amgen out of the field.<span class="mw-ref" id="cite_ref-CetusHist_37-2"><a href="#cite_note-CetusHist-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>151</span></sup>  By 1990 Cetus had gotten aldesleukin approved in nine European countries but in that year, the U.S. Food and Drug Administration (FDA) refused to approve Cetus' application to market IL-2.<span class="mw-ref" id="cite_ref-Pollack_1990_15-1"><a href="#cite_note-Pollack_1990-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> The failure led to the collapse of Cetus, and in 1991 the company was sold to Chiron Corporation.<span class="mw-ref" id="cite_ref-Pollack_1991_40-0"><a href="#cite_note-Pollack_1991-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-Lehrman_1992_41-0"><a href="#cite_note-Lehrman_1992-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> Chiron continued the development of IL-2, which was finally approved by the FDA as Proleukin for metastatic renal carcinoma in 1992.<span class="mw-ref" id="cite_ref-pmid12469934_42-0"><a href="#cite_note-pmid12469934-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span></p>

<p>By 1993 aldesleukin was the only approved version of IL-2, but Roche was also developing a proprietary, modified, recombinant IL-2 called teceleukin, with a <a href="Methionine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methionine" title="Methionine">methionine</a> added at is N-terminal, and Glaxo was developing a version called bioleukin, with a methionine added at is N-terminal and residue 125 replaced with alanine. Dozens of clinical trials had been conducted of recombinant or purified IL-2, alone, in combination with other drugs, or using cell therapies, in which cells were taken from patients, activated with IL-2, then reinfused.<span class="mw-ref" id="cite_ref-Whittington_1993_39-1"><a href="#cite_note-Whittington_1993-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span><span class="mw-ref" id="cite_ref-urlKEGG_DRUG:_D02749_43-0"><a href="#cite_note-urlKEGG_DRUG:_D02749-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span> Novartis acquired Chiron in 2006<span class="mw-ref" id="cite_ref-urlChiron_shareholders_approve_Novartis_deal_-_SWI_swissinfo.ch_44-0"><a href="#cite_note-urlChiron_shareholders_approve_Novartis_deal_-_SWI_swissinfo.ch-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> and licensed the US aldesleukin business to Prometheus Laboratories in 2010<span class="mw-ref" id="cite_ref-urlNovartis_sells_rights_to_Proleukin_in_the_USA_to_Prometheus;_gets_license_for_vaccine_from_IIG;_and_pleads_guilty_over_Trileptal_45-0"><a href="#cite_note-urlNovartis_sells_rights_to_Proleukin_in_the_USA_to_Prometheus;_gets_license_for_vaccine_from_IIG;_and_pleads_guilty_over_Trileptal-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span> before global rights to Proleukin were subsequently acquired by Clinigen in 2018 and 2019.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist columns references-column-width" style="-moz-column-width: 33em; -webkit-column-width: 33em; column-width: 33em; list-style-type: decimal;">
<ol class="mw-references references"><li id="cite_note-refGRCh38Ensembl-1"> <span id="mw-reference-text-cite_note-refGRCh38Ensembl-1" class="mw-reference-text"><a href="javascript:if(confirm('http://may2017.archive.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000109471  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://may2017.archive.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000109471'" tppabs="http://may2017.archive.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000109471" class="external text external">GRCh38: Ensembl release 89: ENSG00000109471</a> - Ensembl, May 2017</span></li><li id="cite_note-refGRCm38Ensembl-2"> <span id="mw-reference-text-cite_note-refGRCm38Ensembl-2" class="mw-reference-text"><a href="javascript:if(confirm('http://may2017.archive.ensembl.org/Mus_musculus/Gene/Summary?db=core;g=ENSMUSG00000027720  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://may2017.archive.ensembl.org/Mus_musculus/Gene/Summary?db=core;g=ENSMUSG00000027720'" tppabs="http://may2017.archive.ensembl.org/Mus_musculus/Gene/Summary?db=core;g=ENSMUSG00000027720" class="external text external">GRCm38: Ensembl release 89: ENSMUSG00000027720</a> - Ensembl, May 2017</span></li><li id="cite_note-3"> <span id="mw-reference-text-cite_note-3" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Link&LinkName=gene_pubmed&from_uid=3558  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Link&LinkName=gene_pubmed&from_uid=3558'" tppabs="https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Link&LinkName=gene_pubmed&from_uid=3558" class="external text external">"Human PubMed Reference:"</a>. <i>National Center for Biotechnology Information, U.S. National Library of Medicine</i>.</cite></span></li><li id="cite_note-4"> <span id="mw-reference-text-cite_note-4" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Link&LinkName=gene_pubmed&from_uid=16183  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Link&LinkName=gene_pubmed&from_uid=16183'" tppabs="https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Link&LinkName=gene_pubmed&from_uid=16183" class="external text external">"Mouse PubMed Reference:"</a>. <i>National Center for Biotechnology Information, U.S. National Library of Medicine</i>.</cite></span></li><li id="cite_note-:0-5"> <span id="mw-reference-text-cite_note-:0-5" class="mw-reference-text"><cite id="CITEREFArenas-RamirezWoytschakBoyman2015" class="citation journal cs1">Arenas-Ramirez N, Woytschak J, Boyman O (December 2015). "Interleukin-2: Biology, Design and Application". <i>Trends in Immunology</i>. <b>36</b> (12): 763–777. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.it.2015.10.003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.it.2015.10.003'" tppabs="https://doi.org/10.1016%2Fj.it.2015.10.003" class="external text external">10.1016/j.it.2015.10.003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26572555  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26572555'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26572555" class="external text external">26572555</a>.</cite></span></li><li id="cite_note-Liao_2011-6"> <span id="mw-reference-text-cite_note-Liao_2011-6" class="mw-reference-text"><cite id="CITEREFLiaoLinLeonard2011" class="citation journal cs1">Liao W, Lin JX, Leonard WJ (October 2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405730  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405730'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405730" class="external text external">"IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation"</a>. <i>Current Opinion in Immunology</i>. <b>23</b> (5): 598–604. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.coi.2011.08.003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.coi.2011.08.003'" tppabs="https://doi.org/10.1016%2Fj.coi.2011.08.003" class="external text external">10.1016/j.coi.2011.08.003</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405730  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405730'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405730" class="external text external">3405730</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21889323  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21889323'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21889323" class="external text external">21889323</a>.</cite></span></li><li id="cite_note-:1-7"> <span id="mw-reference-text-cite_note-:1-7" class="mw-reference-text"><cite id="CITEREFWangRickertGarcia2005" class="citation journal cs1">Wang X, Rickert M, Garcia KC (November 2005). "Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors". <i>Science</i>. <b>310</b> (5751): 1159–63. doi:<a href="javascript:if(confirm('https://doi.org/10.1126%2Fscience.1117893  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1126%2Fscience.1117893'" tppabs="https://doi.org/10.1126%2Fscience.1117893" class="external text external">10.1126/science.1117893</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16293754  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16293754'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16293754" class="external text external">16293754</a>.</cite></span></li><li id="cite_note-Gaffen_2004-8"> <span id="mw-reference-text-cite_note-Gaffen_2004-8" class="mw-reference-text"><cite id="CITEREFGaffenLiu2004" class="citation journal cs1">Gaffen SL, Liu KD (November 2004). "Overview of interleukin-2 function, production and clinical applications". <i>Cytokine</i>. <b>28</b> (3): 109–23. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.cyto.2004.06.010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.cyto.2004.06.010'" tppabs="https://doi.org/10.1016%2Fj.cyto.2004.06.010" class="external text external">10.1016/j.cyto.2004.06.010</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15473953  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15473953'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15473953" class="external text external">15473953</a>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite id="CITEREFFriedmannMigoneRussellLeonard1996" class="citation journal cs1">Friedmann MC, Migone TS, Russell SM, Leonard WJ (March 1996). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC39912  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC39912'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC39912" class="external text external">"Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>93</b> (5): 2077–82. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/1996PNAS...93.2077F  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/1996PNAS...93.2077F'" tppabs="https://ui.adsabs.harvard.edu/abs/1996PNAS...93.2077F" class="external text external">1996PNAS...93.2077F</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1073%2Fpnas.93.5.2077  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1073%2Fpnas.93.5.2077'" tppabs="https://doi.org/10.1073%2Fpnas.93.5.2077" class="external text external">10.1073/pnas.93.5.2077</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC39912  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC39912'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC39912" class="external text external">39912</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8700888  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8700888'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8700888" class="external text external">8700888</a>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite id="CITEREFLiaoLinLeonard2013" class="citation journal cs1">Liao W, Lin JX, Leonard WJ (January 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610532  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610532'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610532" class="external text external">"Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy"</a>. <i>Immunity</i>. <b>38</b> (1): 13–25. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.immuni.2013.01.004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.immuni.2013.01.004'" tppabs="https://doi.org/10.1016%2Fj.immuni.2013.01.004" class="external text external">10.1016/j.immuni.2013.01.004</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610532  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610532'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610532" class="external text external">3610532</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23352221  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23352221'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23352221" class="external text external">23352221</a>.</cite></span></li><li id="cite_note-Malek_2010-11"> <span id="mw-reference-text-cite_note-Malek_2010-11" class="mw-reference-text"><cite id="CITEREFMalekCastro2010" class="citation journal cs1">Malek TR, Castro I (August 2010). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946796  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946796'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946796" class="external text external">"Interleukin-2 receptor signaling: at the interface between tolerance and immunity"</a>. <i>Immunity</i>. <b>33</b> (2): 153–65. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.immuni.2010.08.004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.immuni.2010.08.004'" tppabs="https://doi.org/10.1016%2Fj.immuni.2010.08.004" class="external text external">10.1016/j.immuni.2010.08.004</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946796  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946796'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946796" class="external text external">2946796</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20732639  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20732639'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20732639" class="external text external">20732639</a>.</cite></span></li><li id="cite_note-pmid18288273-12"> <span id="mw-reference-text-cite_note-pmid18288273-12" class="mw-reference-text"><cite id="CITEREFReichSzepietowski2007" class="citation journal cs1">Reich A, Szepietowski JC (2007). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2221678  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2221678'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2221678" class="external text external">"Mediators of pruritus in psoriasis"</a>. <i>Mediators of Inflammation</i>. <b>2007</b>: 1–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1155%2F2007%2F64727  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1155%2F2007%2F64727'" tppabs="https://doi.org/10.1155%2F2007%2F64727" class="external text external">10.1155/2007/64727</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2221678  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2221678'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2221678" class="external text external">2221678</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18288273  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18288273'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18288273" class="external text external">18288273</a>.</cite></span></li><li id="cite_note-pmid18031103-13"> <span id="mw-reference-text-cite_note-pmid18031103-13" class="mw-reference-text"><cite id="CITEREFNobleGoa1997" class="citation journal cs1">Noble S, Goa KL (May 1997). "Aldesleukin (recombinant interleukin-2)". <i>BioDrugs</i>. <b>7</b> (5): 394–422. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00063030-199707050-00007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00063030-199707050-00007'" tppabs="https://doi.org/10.2165%2F00063030-199707050-00007" class="external text external">10.2165/00063030-199707050-00007</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18031103  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18031103'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18031103" class="external text external">18031103</a>.</cite></span></li><li id="cite_note-pmid19544689-14"> <span id="mw-reference-text-cite_note-pmid19544689-14" class="mw-reference-text"><cite id="CITEREFBhatiaTykodiThompson2009" class="citation journal cs1">Bhatia S, Tykodi SS, Thompson JA (May 2009). <a href="javascript:if(confirm('http://www.cancernetwork.com/oncology-journal/treatment-metastatic-melanoma-overview  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cancernetwork.com/oncology-journal/treatment-metastatic-melanoma-overview'" tppabs="http://www.cancernetwork.com/oncology-journal/treatment-metastatic-melanoma-overview" class="external text external">"Treatment of metastatic melanoma: an overview"</a>. <i>Oncology</i>. <b>23</b> (6): 488–96. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737459  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737459'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737459" class="external text external">2737459</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19544689  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19544689'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19544689" class="external text external">19544689</a>.</cite></span></li><li id="cite_note-Pollack_1990-15"> <span id="mw-reference-text-cite_note-Pollack_1990-15" class="mw-reference-text"><cite id="CITEREFPollack_A1990" class="citation web cs1">Pollack A (July 31, 1990). <a href="javascript:if(confirm('https://www.nytimes.com/1990/07/31/business/cetus-drug-is-blocked-by-fda.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/1990/07/31/business/cetus-drug-is-blocked-by-fda.html'" tppabs="https://www.nytimes.com/1990/07/31/business/cetus-drug-is-blocked-by-fda.html" class="external text external">"Cetus Drug Is Blocked By F.D.A."</a> <i>New York Times</i>.</cite> This source mentions approval in 9 European countries.</span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text">Bloombert BusinessWeek.  Last updated March 3, 2014 <a href="javascript:if(confirm('http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=8329:HK  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=8329:HK'" tppabs="http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=8329:HK" class="external text external">Shenzhen Neptunus Interlng-H </a></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite id="CITEREFSilvaYuUlgeSpangler2019" class="citation journal cs1">Silva DA, Yu S, Ulge UY, Spangler JB, Jude KM, Labão-Almeida C, Ali LR, Quijano-Rubio A, Ruterbusch M, Leung I, Biary T, Crowley SJ, Marcos E, Walkey CD, Weitzner BD, Pardo-Avila F, Castellanos J, Carter L, Stewart L, Riddell SR, Pepper M, Bernardes GJ, Dougan M, Garcia KC, Baker D (January 2019). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521699  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521699'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521699" class="external text external">"De novo design of potent and selective mimics of IL-2 and IL-15"</a>. <i>Nature</i>. <b>565</b> (7738): 186–191. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2019Natur.565..186S  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2019Natur.565..186S'" tppabs="https://ui.adsabs.harvard.edu/abs/2019Natur.565..186S" class="external text external">2019Natur.565..186S</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fs41586-018-0830-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fs41586-018-0830-7'" tppabs="https://doi.org/10.1038%2Fs41586-018-0830-7" class="external text external">10.1038/s41586-018-0830-7</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521699  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521699'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521699" class="external text external">6521699</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30626941  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30626941'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30626941" class="external text external">30626941</a>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://neoleukin.com/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://neoleukin.com/'" tppabs="http://neoleukin.com/" class="external text external">"Neoleukin Therapeutics"</a>. <i>neoleukin.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-01-14</span></span>.</cite></span></li><li id="cite_note-American_Cancer_Society-19"> <span id="mw-reference-text-cite_note-American_Cancer_Society-19" class="mw-reference-text">American Cancer Society. <a href="javascript:if(confirm('http://www.cancer.org/Treatment/TreatmentsandSideEffects/GuidetoCancerDrugs/INTERLEUKIN-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cancer.org/Treatment/TreatmentsandSideEffects/GuidetoCancerDrugs/INTERLEUKIN-2'" tppabs="http://www.cancer.org/Treatment/TreatmentsandSideEffects/GuidetoCancerDrugs/INTERLEUKIN-2" class="external text external">Interleukin-2 (Aldesleukin)</a>. Date accessed: 07 Nov 10.</span></li><li id="cite_note-Intralesional_IL_2-20"> <span id="mw-reference-text-cite_note-Intralesional_IL_2-20" class="mw-reference-text"><cite id="CITEREFShiTranPatelLeventhal2015" class="citation journal cs1">Shi VY, Tran K, Patel F, Leventhal J, Konia T, Fung MA, Wilken R, Garcia MS, Fitzmaurice SD, Joo J, Monjazeb AM, Burrall BA, King B, Martinez S, Christensen SD, Maverakis E (October 2015). <a href="javascript:if(confirm('https://doi.org/10.1016/j.jaad.2015.06.060  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/j.jaad.2015.06.060'" tppabs="https://doi.org/10.1016/j.jaad.2015.06.060" class="external text external">"100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series"</a>. <i>Journal of the American Academy of Dermatology</i>. <b>73</b> (4): 645–54. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jaad.2015.06.060  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jaad.2015.06.060'" tppabs="https://doi.org/10.1016%2Fj.jaad.2015.06.060" class="external text external">10.1016/j.jaad.2015.06.060</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26259990  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26259990'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26259990" class="external text external">26259990</a>.</cite></span></li><li id="cite_note-pmid18256831-21"> <span id="mw-reference-text-cite_note-pmid18256831-21" class="mw-reference-text"><cite id="CITEREFDen_OtterJacobsBattermannHordijk2008" class="citation journal cs1">Den Otter W, Jacobs JJ, Battermann JJ, Hordijk GJ, Krastev Z, Moiseeva EV, Stewart RJ, Ziekman PG, Koten JW (July 2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2335290  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2335290'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2335290" class="external text external">"Local therapy of cancer with free IL-2"</a>. <i>Cancer Immunology, Immunotherapy</i>. <b>57</b> (7): 931–50. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00262-008-0455-z  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00262-008-0455-z'" tppabs="https://doi.org/10.1007%2Fs00262-008-0455-z" class="external text external">10.1007/s00262-008-0455-z</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2335290  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2335290'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2335290" class="external text external">2335290</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18256831  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18256831'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18256831" class="external text external">18256831</a>.</cite></span></li><li id="cite_note-pmid15685449-22"> <span id="mw-reference-text-cite_note-pmid15685449-22" class="mw-reference-text"><cite id="CITEREFJacobsSparendamDen_Otter2005" class="citation journal cs1">Jacobs JJ, Sparendam D, Den Otter W (July 2005). "Local interleukin 2 therapy is most effective against cancer when injected intratumourally". <i>Cancer Immunology, Immunotherapy</i>. <b>57</b> (7): 931–50. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00262-004-0627-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00262-004-0627-4'" tppabs="https://doi.org/10.1007%2Fs00262-004-0627-4" class="external text external">10.1007/s00262-004-0627-4</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15685449  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15685449'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15685449" class="external text external">15685449</a>.</cite></span></li><li id="cite_note-pmid15627211-23"> <span id="mw-reference-text-cite_note-pmid15627211-23" class="mw-reference-text"><cite id="CITEREFJacobsHordijkJürgenliemk-SchulzTerhaard2005" class="citation journal cs1">Jacobs JJ, Hordijk GJ, Jürgenliemk-Schulz IM, Terhaard CH, Koten JW, Battermann JJ, Den Otter W (August 2005). "Treatment of stage III-IV nasopharyngeal carcinomas by external beam irradiation and local low doses of IL-2". <i>Cancer Immunol Immunother</i>. <b>57</b> (8): 792–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00262-004-0627-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00262-004-0627-4'" tppabs="https://doi.org/10.1007%2Fs00262-004-0627-4" class="external text external">10.1007/s00262-004-0627-4</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15685449  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15685449'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15685449" class="external text external">15685449</a>.</cite></span></li><li id="cite_note-pmid19009549-24"> <span id="mw-reference-text-cite_note-pmid19009549-24" class="mw-reference-text"><cite id="CITEREFShakerYounes2009" class="citation journal cs1">Shaker MA, Younes HM (July 2009). "Interleukin-2: evaluation of routes of administration and current delivery systems in cancer therapy". <i>Journal of Pharmaceutical Sciences</i>. <b>98</b> (7): 2268–98. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fjps.21596  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fjps.21596'" tppabs="https://doi.org/10.1002%2Fjps.21596" class="external text external">10.1002/jps.21596</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19009549  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19009549'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19009549" class="external text external">19009549</a>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite class="citation journal cs1"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252892  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252892'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252892" class="external text external">"Correction for Krieg et al., Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells"</a>. <i>Proceedings of the National Academy of Sciences</i>. <b>109</b> (1): 345. 2011-12-28. doi:<a href="javascript:if(confirm('https://doi.org/10.1073%2Fpnas.1119897109  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1073%2Fpnas.1119897109'" tppabs="https://doi.org/10.1073%2Fpnas.1119897109" class="external text external">10.1073/pnas.1119897109</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0027-8424  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0027-8424'" tppabs="https://www.worldcat.org/issn/0027-8424" class="external text external">0027-8424</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252892  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252892'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252892" class="external text external">3252892</a></span>.</cite></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text"><cite id="CITEREFFiggittLambGoa2000" class="citation journal cs1">Figgitt DP, Lamb HM, Goa KL (2000). "Denileukin diftitox". <i>American Journal of Clinical Dermatology</i>. <b>1</b> (1): 67–72, discussion 73. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00128071-200001010-00008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00128071-200001010-00008'" tppabs="https://doi.org/10.2165%2F00128071-200001010-00008" class="external text external">10.2165/00128071-200001010-00008</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11702307  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11702307'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11702307" class="external text external">11702307</a>.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm095661.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm095661.htm'" tppabs="https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm095661.htm" class="external text external">"Changes in the Ontak (denileukin diftitiox)"</a>. <i>Package Insert to Include a Description of Ophthalmologic Adverse Events</i>. FDA. May 11, 2009.</cite></span></li><li id="cite_note-28"> <span id="mw-reference-text-cite_note-28" class="mw-reference-text"><cite id="CITEREFTomovaPomakovJacobsAdjarov2006" class="citation journal cs1">Tomova R, Pomakov J, Jacobs JJ, Adjarov D, Popova S, Altankova I, Den Otter W, Krastev Z (May–June 2006). "Changes in cytokine profile during local IL-2 therapy in cancer patients". <i>Anticancer Research</i>. <b>26</b> (3A): 2037–47. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16827142  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16827142'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16827142" class="external text external">16827142</a>.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite id="CITEREFTomovaAntonovIvanovaJacobs2009" class="citation journal cs1">Tomova R, Antonov K, Ivanova A, Jacobs JJ, Koten JW, Den Otter W, Krastev Z (December 2009). "CLow-dose IL-2 therapy reduces HCV RNA and HBV DNA: case report". <i>Anticancer Research</i>. <b>29</b> (12): 5241–4. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20044643  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20044643'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20044643" class="external text external">20044643</a>.</cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.nih.gov/news/health/feb2009/niaid-10.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nih.gov/news/health/feb2009/niaid-10.htm'" tppabs="http://www.nih.gov/news/health/feb2009/niaid-10.htm" class="external text external">"IL-2 Immunotherapy Fails to Benefit HIV-Infected Individuals Already Taking Antiretrovirals"</a>. <i>News Release</i>. National Institutes of Health (NIH). February 10, 2009.</cite></span></li><li id="cite_note-31"> <span id="mw-reference-text-cite_note-31" class="mw-reference-text"><cite id="CITEREFHartemannBensimonPayanJacqueminet2013" class="citation journal cs1">Hartemann A, Bensimon G, Payan CA, Jacqueminet S, Bourron O, Nicolas N, Fonfrede M, Rosenzwajg M, Bernard C, Klatzmann D (December 2013). "Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial". <i>The Lancet. Diabetes &amp; Endocrinology</i>. <b>1</b> (4): 295–305. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS2213-8587%2813%2970113-X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS2213-8587%2813%2970113-X'" tppabs="https://doi.org/10.1016%2FS2213-8587%2813%2970113-X" class="external text external">10.1016/S2213-8587(13)70113-X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24622415  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24622415'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24622415" class="external text external">24622415</a>.</cite></span></li><li id="cite_note-32"> <span id="mw-reference-text-cite_note-32" class="mw-reference-text"><span>Clinical trial number </span><i><a href="javascript:if(confirm('https://www.clinicaltrials.gov/show/NCT03113773  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.clinicaltrials.gov/show/NCT03113773'" tppabs="https://www.clinicaltrials.gov/show/NCT03113773" class="external text external">NCT03113773</a></i><span> for "Low Dose Interleukin-2 in Patients With Stable Ischaemic Heart Disease and Acute Coronary Syndromes (LILACS)" at </span>ClinicalTrials.gov</span></li><li id="cite_note-33"> <span id="mw-reference-text-cite_note-33" class="mw-reference-text"><cite id="CITEREFBoymanKovarRubinsteinSurh2006" class="citation journal cs1">Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J (March 2006). "Selective stimulation of T cell subsets with antibody-cytokine immune complexes". <i>Science</i>. <b>311</b> (5769): 1924–7. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2006Sci...311.1924B  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2006Sci...311.1924B'" tppabs="https://ui.adsabs.harvard.edu/abs/2006Sci...311.1924B" class="external text external">2006Sci...311.1924B</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1126%2Fscience.1122927  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1126%2Fscience.1122927'" tppabs="https://doi.org/10.1126%2Fscience.1122927" class="external text external">10.1126/science.1122927</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16484453  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16484453'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16484453" class="external text external">16484453</a>.</cite></span></li><li id="cite_note-Leonard-34"> <span id="mw-reference-text-cite_note-Leonard-34" class="mw-reference-text"><cite id="CITEREFPaul2008" class="citation book cs1">Paul WE (2008). <i>Fundamental immunology</i> (6th ed.). Philadelphia: Wolters Kluwer/Lippincott Williams &amp; Wilkins. ISBN<span>&nbsp;</span><bdi>978-0-7817-6519-0</bdi>.</cite></span></li><li id="cite_note-pmid20074271-35"> <span id="mw-reference-text-cite_note-pmid20074271-35" class="mw-reference-text"><cite id="CITEREFChavezBuchserBasseLiang2009" class="citation journal cs1">Chavez AR, Buchser W, Basse PH, Liang X, Appleman LJ, Maranchie JK, Zeh H, de Vera ME, Lotze MT (December 2009). "Pharmacologic administration of interleukin-2". <i>Annals of the New York Academy of Sciences</i>. <b>1182</b> (1): 14–27. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2009NYASA1182...14C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2009NYASA1182...14C'" tppabs="https://ui.adsabs.harvard.edu/abs/2009NYASA1182...14C" class="external text external">2009NYASA1182...14C</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1749-6632.2009.05160.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1749-6632.2009.05160.x'" tppabs="https://doi.org/10.1111%2Fj.1749-6632.2009.05160.x" class="external text external">10.1111/j.1749-6632.2009.05160.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20074271  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20074271'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20074271" class="external text external">20074271</a>.</cite></span></li><li id="cite_note-pmid6980256-36"> <span id="mw-reference-text-cite_note-pmid6980256-36" class="mw-reference-text"><cite id="CITEREFWelteWangMertelsmannVenuta1982" class="citation journal cs1">Welte K, Wang CY, Mertelsmann R, Venuta S, Feldman SP, Moore MA (August 1982). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186775  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186775'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186775" class="external text external">"Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity"</a>. <i>The Journal of Experimental Medicine</i>. <b>156</b> (2): 454–64. doi:<a href="javascript:if(confirm('https://doi.org/10.1084%2Fjem.156.2.454  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1084%2Fjem.156.2.454'" tppabs="https://doi.org/10.1084%2Fjem.156.2.454" class="external text external">10.1084/jem.156.2.454</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186775  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186775'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186775" class="external text external">2186775</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6980256  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6980256'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6980256" class="external text external">6980256</a>.</cite></span></li><li id="cite_note-CetusHist-37"> <span id="mw-reference-text-cite_note-CetusHist-37" class="mw-reference-text"><cite id="CITEREFRabinow1997" class="citation book cs1">Rabinow P (1997). <span class="cs1-lock-registration"><a href="javascript:if(confirm('https://archive.org/details/makingpcrstoryof00rabi  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/makingpcrstoryof00rabi'" tppabs="https://archive.org/details/makingpcrstoryof00rabi" class="external text external"><i>Making PCR: A story of biotechnology</i></a></span> (Paperback ed.). Chicago, IL, USA: University of Chicago Press. ISBN<span>&nbsp;</span><bdi>978-0226701479</bdi>.</cite></span></li><li id="cite_note-38"> <span id="mw-reference-text-cite_note-38" class="mw-reference-text"><cite id="CITEREFAlmeida2011" class="citation journal cs1">Almeida H (April–June 2011). <a href="javascript:if(confirm('http://www.scielo.br/pdf/bjps/v47n2/v47n2a02.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.scielo.br/pdf/bjps/v47n2/v47n2a02.pdf'" tppabs="http://www.scielo.br/pdf/bjps/v47n2/v47n2a02.pdf" class="external text external">"Drugs obtained by biotechnology processing"</a> <span class="cs1-format">(PDF)</span>. <i>Brazilian Journal of Pharmaceutical Sciences</i>. <b>47</b> (2): 199–207. doi:<a href="javascript:if(confirm('https://doi.org/10.1590%2Fs1984-82502011000200002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1590%2Fs1984-82502011000200002'" tppabs="https://doi.org/10.1590%2Fs1984-82502011000200002" class="external text external">10.1590/s1984-82502011000200002</a>.</cite></span></li><li id="cite_note-Whittington_1993-39"> <span id="mw-reference-text-cite_note-Whittington_1993-39" class="mw-reference-text"><cite id="CITEREFWhittingtonFaulds1993" class="citation journal cs1">Whittington R, Faulds D (September 1993). "Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer". <i>Drugs</i>. <b>46</b> (3): 446–514. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-199346030-00009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-199346030-00009'" tppabs="https://doi.org/10.2165%2F00003495-199346030-00009" class="external text external">10.2165/00003495-199346030-00009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7693434  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7693434'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7693434" class="external text external">7693434</a>.</cite></span></li><li id="cite_note-Pollack_1991-40"> <span id="mw-reference-text-cite_note-Pollack_1991-40" class="mw-reference-text"><cite id="CITEREFPollack1991" class="citation web cs1">Pollack A (July 23, 1991). <a href="javascript:if(confirm('https://www.nytimes.com/1991/07/23/business/2-biotech-pioneers-to-merge.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/1991/07/23/business/2-biotech-pioneers-to-merge.html'" tppabs="https://www.nytimes.com/1991/07/23/business/2-biotech-pioneers-to-merge.html" class="external text external">"2 Biotech Pioneers To Merge"</a>. <i>New York Times</i>.</cite></span></li><li id="cite_note-Lehrman_1992-41"> <span id="mw-reference-text-cite_note-Lehrman_1992-41" class="mw-reference-text"><cite id="CITEREFLehrman1992" class="citation web cs1">Lehrman S (January 20, 1992). <a href="javascript:if(confirm('http://www.the-scientist.com/?articles.view/articleNo/12113/title/Cetus  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.the-scientist.com/?articles.view/articleNo/12113/title/Cetus'" tppabs="http://www.the-scientist.com/?articles.view/articleNo/12113/title/Cetus" class="external text external">– A-Collision-Course-With-Failure/ "Cetus: A Collision Course With Failure"</a><span class="cs1-visible-error error citation-comment"> Check <code class="cs1-code"><span>|</span>url=</code> value (help)</span>. <i>The Scientist Magazine</i>.</cite></span></li><li id="cite_note-pmid12469934-42"> <span id="mw-reference-text-cite_note-pmid12469934-42" class="mw-reference-text"><cite id="CITEREFDutcher2002" class="citation journal cs1">Dutcher JP (November 2002). "Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma". <i>Oncology</i>. <b>16</b> (11 Suppl 13): 4–10. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12469934  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12469934'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12469934" class="external text external">12469934</a>.</cite></span></li><li id="cite_note-urlKEGG_DRUG:_D02749-43"> <span id="mw-reference-text-cite_note-urlKEGG_DRUG:_D02749-43" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.genome.jp/dbget-bin/www_bget?dr:D02749  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.genome.jp/dbget-bin/www_bget?dr:D02749'" tppabs="http://www.genome.jp/dbget-bin/www_bget?dr:D02749" class="external text external">"D02749 (Teceleukin)"</a>. <i>KEGG drug</i>.</cite></span></li><li id="cite_note-urlChiron_shareholders_approve_Novartis_deal_-_SWI_swissinfo.ch-44"> <span id="mw-reference-text-cite_note-urlChiron_shareholders_approve_Novartis_deal_-_SWI_swissinfo.ch-44" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.swissinfo.ch/eng/chiron-shareholders-approve-novartis-deal/5134216  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.swissinfo.ch/eng/chiron-shareholders-approve-novartis-deal/5134216'" tppabs="http://www.swissinfo.ch/eng/chiron-shareholders-approve-novartis-deal/5134216" class="external text external">"Chiron shareholders approve Novartis deal"</a>. <i>SWI swissinfo.ch</i>. Apr 19, 2006.</cite></span></li><li id="cite_note-urlNovartis_sells_rights_to_Proleukin_in_the_USA_to_Prometheus;_gets_license_for_vaccine_from_IIG;_and_pleads_guilty_over_Trileptal-45"> <span id="mw-reference-text-cite_note-urlNovartis_sells_rights_to_Proleukin_in_the_USA_to_Prometheus;_gets_license_for_vaccine_from_IIG;_and_pleads_guilty_over_Trileptal-45" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.thepharmaletter.com/article/novartis-sells-rights-to-proleukin-in-the-usa-to-prometheus-gets-license-for-vaccine-from-iig-and-pleads-guilty-over-trileptal  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.thepharmaletter.com/article/novartis-sells-rights-to-proleukin-in-the-usa-to-prometheus-gets-license-for-vaccine-from-iig-and-pleads-guilty-over-trileptal'" tppabs="http://www.thepharmaletter.com/article/novartis-sells-rights-to-proleukin-in-the-usa-to-prometheus-gets-license-for-vaccine-from-iig-and-pleads-guilty-over-trileptal" class="external text external">"Novartis sells rights to Proleukin in the USA to Prometheus; gets license for vaccine from IIG; and pleads guilty over Trileptal"</a>. <i>Pharmaletter</i>. January 27, 2010.</cite></span></li></ol></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<table role="presentation" class="mbox-small  sistersitebox" style="background-color:#f9f9f9;border:1px solid #aaa;color:#000">
<tbody><tr>
<td class="mbox-image"><figure-inline class="noviewer"><span><img src="../I/m/Commons-logo.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Commons-logo.svg.png" data-file-width="1024" data-file-height="1376" data-file-type="drawing" height="40" width="30"></span></figure-inline></td>
<td class="mbox-text plainlist">Wikimedia Commons has media related to <i><b><a href="javascript:if(confirm('https://commons.wikimedia.org/wiki/Category:Interleukin-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://commons.wikimedia.org/wiki/Category:Interleukin-2'" tppabs="https://commons.wikimedia.org/wiki/Category:Interleukin-2" title="commons:Category:Interleukin-2" class="external"><span style=" ">Interleukin-2</span></a></b></i>.</td></tr>
</tbody></table>
<ul><li><a href="javascript:if(confirm('http://www.proleukin.com/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.proleukin.com/'" tppabs="http://www.proleukin.com/" class="external text external">Proleukin website</a></li>
<li><a href="javascript:if(confirm('http://www.netpath.org/pathways?path_id=NetPath_14  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.netpath.org/pathways?path_id=NetPath_14'" tppabs="http://www.netpath.org/pathways?path_id=NetPath_14" class="external text external">IL-2 Signaling Pathway</a></li>
<li><cite id="CITEREFRosenberg2014" class="citation journal cs1">Rosenberg SA (June 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293462  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293462'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293462" class="external text external">"IL-2: the first effective immunotherapy for human cancer"</a>. <i>Journal of Immunology</i>. <b>192</b> (12): 5451–8. doi:<a href="javascript:if(confirm('https://doi.org/10.4049%2Fjimmunol.1490019  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4049%2Fjimmunol.1490019'" tppabs="https://doi.org/10.4049%2Fjimmunol.1490019" class="external text external">10.4049/jimmunol.1490019</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293462  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293462'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293462" class="external text external">6293462</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24907378  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24907378'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24907378" class="external text external">24907378</a>.</cite></li>
<li><span>Overview of all the structural information available in the </span>PDB<span> for </span>UniProt<span>: </span><i><a href="javascript:if(confirm('https://www.ebi.ac.uk/pdbe/pdbe-kb/proteins/P60568  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/pdbe/pdbe-kb/proteins/P60568'" tppabs="https://www.ebi.ac.uk/pdbe/pdbe-kb/proteins/P60568" class="external text external">P60568</a></i><span> (Interleukin-2) at the </span>PDBe-KB<span>.</span></li></ul>

<div role="navigation" class="navbox" aria-labelledby="PDB_gallery" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="background:#e7dcc3"><div id="PDB_gallery" style="font-size:114%;margin:0 4em">PDB gallery</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em"><ul class="gallery mw-gallery-traditional nochecker" style="line-height:130%">
<li class="gallerybox" style="width: 215px;"><div class="thumb" style="width: 210px; height: 210px;"><figure-inline><img src="../I/m/PDB_1irl_EBI.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/PDB_1irl_EBI.jpg" data-file-width="800" data-file-height="600" data-file-type="bitmap" height="135" width="180"></figure-inline></div><div class="gallerytext"><b>1irl</b>: THE SOLUTION STRUCTURE OF THE F42A MUTANT OF HUMAN INTERLEUKIN 2</div></li>
<li class="gallerybox" style="width: 215px;"><div class="thumb" style="width: 210px; height: 210px;"><figure-inline><img src="../I/m/PDB_1m47_EBI.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/PDB_1m47_EBI.jpg" data-file-width="800" data-file-height="600" data-file-type="bitmap" height="135" width="180"></figure-inline></div><div class="gallerytext"><b>1m47</b>: Crystal Structure of Human Interleukin-2</div></li>
<li class="gallerybox" style="width: 215px;"><div class="thumb" style="width: 210px; height: 210px;"><figure-inline><img src="../I/m/PDB_1m48_EBI.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/PDB_1m48_EBI.jpg" data-file-width="800" data-file-height="600" data-file-type="bitmap" height="135" width="180"></figure-inline></div><div class="gallerytext"><b>1m48</b>: Crystal Structure of Human IL-2 Complexed with (R)-N-[2-[1-(Aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-L-phenylalanine methyl ester</div></li>
<li class="gallerybox" style="width: 215px;"><div class="thumb" style="width: 210px; height: 210px;"><figure-inline><img src="../I/m/PDB_1m49_EBI.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/PDB_1m49_EBI.jpg" data-file-width="800" data-file-height="600" data-file-type="bitmap" height="135" width="180"></figure-inline></div><div class="gallerytext"><b>1m49</b>: Crystal Structure of Human Interleukin-2 Complexed with SP-1985</div></li>
<li class="gallerybox" style="width: 215px;"><div class="thumb" style="width: 210px; height: 210px;"><figure-inline><img src="../I/m/PDB_1m4a_EBI.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/PDB_1m4a_EBI.jpg" data-file-width="800" data-file-height="600" data-file-type="bitmap" height="135" width="180"></figure-inline></div><div class="gallerytext"><b>1m4a</b>: Crystal Structure of Human Interleukin-2 Y31C Covalently Modified at C31 with (1H-Indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid</div></li>
<li class="gallerybox" style="width: 215px;"><div class="thumb" style="width: 210px; height: 210px;"><figure-inline><img src="../I/m/PDB_1m4b_EBI.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/PDB_1m4b_EBI.jpg" data-file-width="800" data-file-height="600" data-file-type="bitmap" height="135" width="180"></figure-inline></div><div class="gallerytext"><b>1m4b</b>: Crystal Structure of Human Interleukin-2 K43C Covalently Modified at C43 with 2-[2-(2-Cyclohexyl-2-guanidino-acetylamino)-acetylamino]-N-(3-mercapto-propyl)-propionamide</div></li>
<li class="gallerybox" style="width: 215px;"><div class="thumb" style="width: 210px; height: 210px;"><figure-inline><img src="../I/m/PDB_1m4c_EBI.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/PDB_1m4c_EBI.jpg" data-file-width="800" data-file-height="600" data-file-type="bitmap" height="135" width="180"></figure-inline></div><div class="gallerytext"><b>1m4c</b>: Crystal Structure of Human Interleukin-2</div></li>
<li class="gallerybox" style="width: 215px;"><div class="thumb" style="width: 210px; height: 210px;"><figure-inline><img src="../I/m/PDB_1nbp_EBI.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/PDB_1nbp_EBI.jpg" data-file-width="800" data-file-height="600" data-file-type="bitmap" height="135" width="180"></figure-inline></div><div class="gallerytext"><b>1nbp</b>: Crystal Structure Of Human Interleukin-2 Y31C Covalently Modified At C31 With 3-Mercapto-1-(1,3,4,9-tetrahydro-B-carbolin-2-yl)-propan-1-one</div></li>
<li class="gallerybox" style="width: 215px;"><div class="thumb" style="width: 210px; height: 210px;"><figure-inline><img src="../I/m/PDB_1pw6_EBI.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/PDB_1pw6_EBI.jpg" data-file-width="800" data-file-height="600" data-file-type="bitmap" height="135" width="180"></figure-inline></div><div class="gallerytext"><b>1pw6</b>: Low Micromolar Small Molecule Inhibitor of IL-2</div></li>
<li class="gallerybox" style="width: 215px;"><div class="thumb" style="width: 210px; height: 210px;"><figure-inline><img src="../I/m/PDB_1py2_EBI.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/PDB_1py2_EBI.jpg" data-file-width="800" data-file-height="600" data-file-type="bitmap" height="135" width="180"></figure-inline></div><div class="gallerytext"><b>1py2</b>: Structure of a 60 nM Small Molecule Bound to a Hot Spot on IL-2</div></li>
<li class="gallerybox" style="width: 215px;"><div class="thumb" style="width: 210px; height: 210px;"><figure-inline><img src="../I/m/PDB_1qvn_EBI.png" tppabs="https://ptable.com/wiki/compounds/I/m/PDB_1qvn_EBI.png" data-file-width="800" data-file-height="600" data-file-type="bitmap" height="135" width="180"></figure-inline></div><div class="gallerytext"><b>1qvn</b>: Structure of SP4160 Bound to IL-2 V69A</div></li>
<li class="gallerybox" style="width: 215px;"><div class="thumb" style="width: 210px; height: 210px;"><figure-inline><img src="../I/m/PDB_1z92_EBI.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/PDB_1z92_EBI.jpg" data-file-width="800" data-file-height="600" data-file-type="bitmap" height="135" width="180"></figure-inline></div><div class="gallerytext"><b>1z92</b>: structure of interleukin-2 with its alpha receptor</div></li>
<li class="gallerybox" style="width: 215px;"><div class="thumb" style="width: 210px; height: 210px;"><figure-inline><img src="../I/m/PDB_2b5i_EBI.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/PDB_2b5i_EBI.jpg" data-file-width="800" data-file-height="600" data-file-type="bitmap" height="135" width="180"></figure-inline></div><div class="gallerytext"><b>2b5i</b>: cytokine receptor complex</div></li>
<li class="gallerybox" style="width: 215px;"><div class="thumb" style="width: 210px; height: 210px;"><figure-inline><img src="../I/m/PDB_2erj_EBI.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/PDB_2erj_EBI.jpg" data-file-width="800" data-file-height="600" data-file-type="bitmap" height="135" width="180"></figure-inline></div><div class="gallerytext"><b>2erj</b>: Crystal structure of the heterotrimeric interleukin-2 receptor in complex with interleukin-2</div></li>
<li class="gallerybox" style="width: 215px;"><div class="thumb" style="width: 210px; height: 210px;"><figure-inline><img src="../I/m/PDB_3ink_EBI.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/PDB_3ink_EBI.jpg" data-file-width="800" data-file-height="600" data-file-type="bitmap" height="135" width="180"></figure-inline></div><div class="gallerytext"><b>3ink</b>: UNRAVELING THE STRUCTURE OF INTERLEUKIN-2: REPLY</div></li>
</ul></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Cell_signaling:_cytokines" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Cell_signaling:_cytokines" style="font-size:114%;margin:0 4em">Cell signaling: cytokines</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">By family</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Chemokine</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">CCL</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>CCL1</li>
<li>CCL2/MCP1</li>
<li>CCL3/MIP1α</li>
<li>CCL4/MIP1β</li>
<li>CCL5/RANTES</li>
<li>CCL6</li>
<li>CCL7</li>
<li>CCL8</li>
<li>CCL9</li>
<li>CCL11</li>
<li>CCL12</li>
<li>CCL13</li>
<li>CCL14</li>
<li>CCL15</li>
<li>CCL16</li>
<li>CCL17</li>
<li>CCL18/PARC/DCCK1/AMAC1/MIP4</li>
<li>CCL19</li>
<li>CCL20</li>
<li>CCL21</li>
<li>CCL22</li>
<li>CCL23</li>
<li>CCL24</li>
<li>CCL25</li>
<li>CCL26</li>
<li>CCL27</li>
<li>CCL28</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">CXCL</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>CXCL1/KC</li>
<li>CXCL2</li>
<li>CXCL3</li>
<li>CXCL4</li>
<li>CXCL5</li>
<li>CXCL6</li>
<li>CXCL7</li>
<li>CXCL8/IL8</li>
<li>CXCL9</li>
<li>CXCL10</li>
<li>CXCL11</li>
<li>CXCL12</li>
<li>CXCL13</li>
<li>CXCL14</li>
<li>CXCL15</li>
<li>CXCL16</li>
<li>CXCL17</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">CX3CL</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>CX3CL1</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">XCL</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>XCL1</li>
<li>XCL2</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Tumor_necrosis_factors.htm" tppabs="https://ptable.com/wiki/compounds/A/Tumor_necrosis_factors" title="Tumor necrosis factors" class="mw-redirect">TNF</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>TNFA</li>
<li>Lymphotoxin
<ul><li>TNFB/LTA</li>
<li>TNFC/LTB</li></ul></li>
<li>TNFSF4</li>
<li>TNFSF5/CD40LG</li>
<li>TNFSF6</li>
<li>TNFSF7</li>
<li>TNFSF8</li>
<li>TNFSF9</li>
<li>TNFSF10</li>
<li>TNFSF11</li>
<li>TNFSF13</li>
<li>TNFSF13B</li>
<li>EDA</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Interleukin</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Type I<br>(grouped by<br>receptor<br>subunit)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">γ chain</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Interleukin_2.htm" tppabs="https://ptable.com/wiki/compounds/A/Interleukin_2" title="Interleukin 2">IL2</a>/IL15</li>
<li>IL4/IL13</li>
<li>IL7</li>
<li>IL9</li>
<li>IL21</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">β chain</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>IL3</li>
<li>IL5</li>
<li>GMCSF</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">IL6 like/gp130</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>IL6</li>
<li>IL11</li>
<li>IL27</li>
<li>IL30</li>
<li>IL31
<ul><li>+non IL OSM</li>
<li>LIF</li>
<li>CNTF</li>
<li>CTF1</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><span class="new">IL12 family</span>/IL12RB1</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>IL12</li>
<li>IL23</li>
<li>IL27</li>
<li>IL35</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>IL14</li>
<li>IL16</li>
<li>IL32</li>
<li>IL34</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Type II</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">IL10 family</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>IL10/IL22</li>
<li>IL19</li>
<li>IL20</li>
<li>IL24</li>
<li>IL26</li>
<li>Interferon type III
<ul><li>IL28/IFNL2+3</li>
<li>IL29/IFNL1</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Interferon</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">I</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>IFNA1</li>
<li>IFNA2</li>
<li>IFNA4</li>
<li>IFNA5</li>
<li>IFNA6</li>
<li>IFNA7</li>
<li>IFNA8</li>
<li>IFNA10</li>
<li>IFNA13</li>
<li>IFNA14</li>
<li>IFNA16</li>
<li>IFNA17</li>
<li>IFNA21</li>
<li>IFNB1</li>
<li>IFNK</li>
<li>IFNW1</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">II</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>IFNG</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Ig superfamily</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>IL1 family: IL1A/IL1F1</li>
<li>IL1B/IL1F2</li>
<li>1Ra/IL1F3</li>
<li>IL1F5</li>
<li>IL1F6</li>
<li>IL1F7</li>
<li>IL1F8</li>
<li>IL1F9</li>
<li>IL1F10</li>
<li>33/IL1F11</li>
<li>18/IL1G</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">IL17 family</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>IL17/IL25 (IL17A)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Hematopoietic
<ul><li>KITLG</li>
<li>Colony-stimulating factor</li></ul></li>
<li>SPP1</li>
<li>MIF</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">By function/<br>cell</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>proinflammatory cytokine</i>
<ul><li>IL1</li>
<li>TNFA</li></ul></li></ul>

<ul><li>Monokine</li>
<li>Lymphokine
<ul><li><i>T<sub>h</sub>1</i>
<ul><li>IFNγ</li>
<li>TNFβ</li></ul></li>
<li><i>T<sub>h</sub>2</i>
<ul><li>IL4</li>
<li>IL5</li>
<li>IL6</li>
<li>IL10</li>
<li>IL13</li></ul></li></ul></li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Interleukin_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Interleukin_receptor_modulators" style="font-size:114%;margin:0 4em">Interleukin receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-1</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Interleukin 1 (α, β)</li>
<li><span class="new">Mobenakin</span></li>
<li><span class="new">Pifonakin</span></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">AF-12198</span></li>
<li><a href="Anakinra.htm" tppabs="https://ptable.com/wiki/compounds/A/Anakinra" title="Anakinra">Anakinra</a></li>
<li>IL-1RA</li>
<li><span class="new">Isunakinra</span></li></ul>

<ul><li><i>Antibodies:</i> Canakinumab</li>
<li>Gevokizumab</li>
<li><span class="new">Lutikizumab</span></li></ul>

<ul><li><i>Decoy receptors:</i> Rilonacept (IL-1 Trap)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-2</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">Adargileukin alfa</span></li>
<li><a href="Interleukin_2.htm" tppabs="https://ptable.com/wiki/compounds/A/Aldesleukin" title="Aldesleukin" class="mw-redirect">Aldesleukin</a></li>
<li><span class="new">Celmoleukin</span></li>
<li><a href="Denileukin_diftitox.htm" tppabs="https://ptable.com/wiki/compounds/A/Denileukin_diftitox" title="Denileukin diftitox">Denileukin diftitox</a></li>
<li><a href="Interleukin_2.htm" tppabs="https://ptable.com/wiki/compounds/A/Interleukin_2" title="Interleukin 2">Interleukin 2</a></li>
<li><span class="new">Pegaldesleukin</span></li>
<li><span class="new">Teceleukin</span></li>
<li>Tucotuzumab celmoleukin</li></ul>

<ul><li><i>Antibodies:</i> <a href="Basiliximab.htm" tppabs="https://ptable.com/wiki/compounds/A/Basiliximab" title="Basiliximab">Basiliximab</a></li>
<li><a href="Daclizumab.htm" tppabs="https://ptable.com/wiki/compounds/A/Daclizumab" title="Daclizumab">Daclizumab (dacliximab)</a></li>
<li>Inolimomab</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-3</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">Daniplestim</span></li>
<li>Interleukin 3</li>
<li><span class="new">Leridistim</span></li>
<li><span class="new">Milodistim</span></li>
<li><span class="new">Muplestim</span></li>
<li>Promegapoietin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-4</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">Binetrakin</span></li>
<li>Interleukin 4</li>
<li>Interleukin 13</li></ul>

<ul><li><i>Antagonists:</i> Pitrakinra</li></ul>

<ul><li><i>Antibodies:</i> Dupilumab</li>
<li>Pascolizumab</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-5</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Interleukin 5</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">YM-90709</span></li></ul>

<ul><li><i>Antibodies:</i> Benralizumab</li>
<li>Mepolizumab</li>
<li>Reslizumab</li></ul>

<ul><li><i>Antisense oligonucleotides:</i> <span class="new">TPI ASM8</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-6</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">Atexakin alfa</span></li>
<li>Interleukin 6</li></ul>

<ul><li><i>Antibodies:</i> <span class="new">ARGX-109</span></li>
<li>Clazakizumab</li>
<li>Elsilimomab</li>
<li><span class="new">mAb 1339</span></li>
<li>Olokizumab</li>
<li>Sarilumab</li>
<li>Siltuximab</li>
<li>Sirukumab</li>
<li>Tocilizumab</li>
<li><span class="new">Levilimab</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-7</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Interleukin 7</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-8</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See CXCR1 (IL-8Rα) and CXCR2 (IL-8Rβ) here instead.</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-9</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Interleukin 9</li></ul>

<ul><li><i>Antibodies:</i> <span class="new">Enokizumab</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-10</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">Ilodecakin</span></li>
<li>Interleukin 10 (CSIF)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-11</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Interleukin 11 (AGIF)</li>
<li><a href="Oprelvekin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oprelvekin" title="Oprelvekin">Oprelvekin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-12</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">Edodekin alfa</span></li>
<li>Interleukin 12</li></ul>

<ul><li><i>Antibodies:</i> Briakinumab</li>
<li>Ustekinumab</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-13</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">Binetrakin</span></li>
<li><span class="new">Cintredekin besudotox</span></li>
<li>Interleukin 4</li>
<li>Interleukin 13</li></ul>

<ul><li><i>Antibodies:</i> Anrukinzumab</li>
<li>Lebrikizumab</li>
<li>Tralokinumab</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-15</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> ALT-803</li>
<li>Interleukin 15</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-17</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Interleukin 17 (A, <span class="new">B</span>, <span class="new">C</span>, <span class="new">D</span>, E (interleukin 25), <span class="new">F</span>)</li></ul>

<ul><li><i>Antibodies:</i> Brodalumab</li>
<li>Ixekizumab</li>
<li>Perakizumab</li>
<li><span class="new">Remtolumab</span></li>
<li>Secukinumab</li>
<li><span class="new">Vunakizumab</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-18</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">Iboctadekin</span></li>
<li>Interleukin 18</li>
<li>Interleukin 37</li>
<li><span class="new">Tadekinig</span></li></ul>

<ul><li><i>Binding proteins:</i> IL18BP</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-20</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Interleukin 19</li>
<li>Interleukin 20</li>
<li>Interleukin 24</li></ul>

<ul><li><i>Antibodies:</i> Fletikumab (against IL-20)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-21</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">Denenicokin</span></li>
<li>Interleukin 21</li></ul>

<ul><li><i>Antibodies:</i> <span class="new">NNC0114-0005</span></li>
<li><span class="new">NNC0114-0006</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-22</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Interleukin 22</li></ul>

<ul><li><i>Antibodies:</i> Fezakinumab (against IL-22)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-23</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Interleukin 23 (SGRF)</li></ul>

<ul><li><i>Antibodies:</i> Brazikumab</li>
<li>Briakinumab</li>
<li>Guselkumab</li>
<li>Risankizumab</li>
<li>Tildrakizumab</li>
<li>Ustekinumab</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-27</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Interleukin 27 (interleukin 30)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-28</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">Interferon λ4 (IFN-λ4)</span></li>
<li>Interleukin 28 (<span class="new">A (IFN-λ2)</span>, B (IFN-λ3))</li>
<li>Interleukin-29 (IFN-λ1)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL-31</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Interleukin 31</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL1RL1</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Interleukin 33</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">IL1RL2</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> Interleukin 36 (α, β, γ)</li>
<li>Interleukin 38</li></ul>

<ul><li><i>Antagonists:</i> IL-36RA</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">JAK</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Interleukin 14 (taxilin alpha, HMW-BCGF)</li>
<li>Interleukin 16 (signals through CD4)</li>
<li>Interleukin 24 (signals through IL-22Rα1/IL-20Rβ heterodimer)</li>
<li>Interleukin 26 (signals through IL-20Rα/IL-10Rβ heterodimer)</li>
<li>Interleukin 32</li>
<li>Interleukin 34 (signals through M-CSFR/CSF1R)</li>
<li>Interleukin 35</li></ul>

<ul><li><i>Unsorted:</i> <span class="new">Efavaleukin alfa</span></li>
<li><span class="new">Efineptakin alfa</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd><i>Receptor/signaling modulators</i></dd>
<dd><i>Signaling peptide/protein receptor modulators</i></dd>
<dd><i>Cytokine receptor modulators</i></dd></dl>
</div></td></tr></tbody></table></div>





<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-05-22" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Interleukin_2&oldid=958246645  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Interleukin_2&oldid=958246645'" tppabs="https://en.wikipedia.org/wiki/?title=Interleukin_2&oldid=958246645">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>